2023 PCE Oncology Spring Conferences – Hematologic Malignancies

PCE, the national leader in continuing education for NPs and PAs, presents the 2023 PCE Oncology Spring Conferences – Hematologic Malignancies. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Review the latest evidence-based strategies for contemporary care of your patients with hematologic malignancies with downloadable slides from CCO and PCE. 

Share

Program Content

Activities

Managing CLL/SLL and MCL
Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2023

Managing CLL/SLL and MCL with BTKis
Current and Novel Approaches to the Management of Patients With CLL/SLL and MCL Using BTK Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 25, 2023

BTKi and BCL-2i in MCL and CLL/SLL
Mastering the Use of BTK- and BCL2- Inhibitors in the Management of MCL and CLL/SLL
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: June 27, 2023

Expires: June 26, 2024

Activities

CAR T Nursing Practice
Navigating the New Advances in CAR T-Cell Therapy: Clinical Applications for Nursing Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Activities

Myelofibrosis Care
A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review and Case Challenges Illustrating Current Therapeutic Standards
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from AstraZeneca; Bristol-Myers Squibb; CTI BioPharma Corp; GSK; and Incyte Corporation.

AstraZeneca

Bristol Myers Squibb

CTI BioPharma Corp., a Sobi Company

GSK

Incyte Corporation